Ignite Creation Date:
2024-05-05 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00116389
Status:
TERMINATED
Last Update Posted:
2007-06-08
First Post:
2005-06-28
Brief Title:
Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas
Sponsor:
Point Therapeutics
Organization:
Point Therapeutics
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Adenocarcinoma |
| Pancreatic Cancer |
| Neoplasm Metastasis |